ArticleJournal of clinical medicine research2024

Addition of Sacubitril/Valsartan to Mineralocorticoid Receptor Antagonist Therapy in Primary Aldosteronism: Effects on Plasma Aldosterone Concentration and Plasma Renin Activity.

Keisuke Okamura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.